Display options
Share it on

Saudi J Biol Sci. 2020 Jan;27(1):407-411. doi: 10.1016/j.sjbs.2019.11.001. Epub 2019 Nov 18.

Tobacco smoking causes secondary polycythemia and a mild leukocytosis among heavy smokers in Taif City in Saudi Arabia.

Saudi journal of biological sciences

Adel Qlayel Alkhedaide

Affiliations

  1. Laboratory Technology Department, Turabah University College, Taif University, 5137, Unit No. 1, At Taif 26522 - 7360, Saudi Arabia.

PMID: 31889864 PMCID: PMC6933161 DOI: 10.1016/j.sjbs.2019.11.001

Abstract

Tobacco smoking is a common risk factor of cardiovascular diseases, cancers and heart health problems. In Taif, the number of secondary polycythemia patients is increasing dramatically and most of those patients are heavy smokers. Therefore, this study is an attempt to understand the pathophysiological mechanism behind that problem. Whole blood and serum samples were collected from forty healthy people and forty tobacco smokers, voluntary for this study. Complete blood counts revealed a significant increase in the red blood cell count, hemoglobin concentrations, hematocrit and neutrophils with some elevations in total white blood cells, lymphocytes and monocytes. Moreover, serum analysis of both erythropoietin and interleukin-7 showed a significant reduction in their levels among smokers which were about 35% and 65% respectively. Gene expression study showed a significant upregulation of RAG-1, RAG-2 and EPOR-1 genes caused by tobacco smoking. In conclusion, data presented in the current study suggest that tobacco smoking might cause alveolar tissue inflammation and vascular injury causing an immune response that elevates the white blood cells count. Another suggestion is that tobacco smoking defects the pulmonary gaseous exchange mechanism leading to the secondary polycythemia indicated by the increase in red blood cell count, hemoglobin levels, hematocrit and by the low serum erythropoietin levels.

© 2019 The Author(s).

Keywords: EPOR-1; Erythropoietin; IL-7; Leukocytosis; Polycythemia; RAG-1; RAG-2; Secondary; Smoking

Conflict of interest statement

The author declare that he has no competing interests and this research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

References

  1. J Clin Periodontol. 2011 Mar;38(3):219-28 - PubMed
  2. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4495-9 - PubMed
  3. Am Rev Respir Dis. 1982 May;125(5):507-10 - PubMed
  4. Blood. 2002 Jun 1;99(11):3892-904 - PubMed
  5. JCI Insight. 2018 Feb 8;3(3): - PubMed
  6. Eur Respir J. 2011 Sep;38(3):617-27 - PubMed
  7. Nouv Rev Fr Hematol. 1993 Apr;35(2):141-4 - PubMed
  8. Intern Med. 1997 Oct;36(10):680-4 - PubMed
  9. Prev Med Rep. 2016 Aug 09;4:417-22 - PubMed
  10. Ann Epidemiol. 1994 May;4(3):236-42 - PubMed
  11. J Immunol. 2012 Jun 15;188(12):6084-92 - PubMed
  12. Conn Med. 2012 Feb;76(2):69-72 - PubMed
  13. Nat Immunol. 2008 Jun;9(6):613-22 - PubMed
  14. Conn Med. 2013 Jun-Jul;77(6):353-5 - PubMed
  15. Biomarkers. 2014 Aug;19(5):368-77 - PubMed
  16. Immunity. 2008 Mar;28(3):335-45 - PubMed
  17. Arch Pathol Lab Med. 1987 Nov;111(11):1081 - PubMed
  18. Mayo Clin Proc. 2018 Mar;93(3):337-343 - PubMed
  19. PLoS One. 2017 Sep 18;12(9):e0184914 - PubMed
  20. Am J Epidemiol. 1991 Dec 15;134(12):1402-9 - PubMed
  21. J R Soc Med. 1988 Feb;81(2):89-91 - PubMed
  22. Anticancer Res. 2017 Mar;37(3):963-967 - PubMed
  23. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):846-51 - PubMed
  24. J Dent Res. 2012 Feb;91(2):142-9 - PubMed
  25. N Engl J Med. 1978 Jan 5;298(1):6-10 - PubMed
  26. Cardiovasc Diabetol. 2012 Sep 27;11:116 - PubMed
  27. Curr Opin Immunol. 2007 Apr;19(2):123-8 - PubMed
  28. J Indian Soc Periodontol. 2016 May-Jun;20(3):249-53 - PubMed
  29. FASEB J. 2003 Jun;17(9):1127-9 - PubMed
  30. Blood. 1973 Jun;41(6):845-51 - PubMed

Publication Types